Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-01-02 @ 4:11 AM
Study NCT ID:
NCT05242432
Status:
TERMINATED
Last Update Posted:
2025-05-23
First Post:
2022-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants
Sponsor:
Janssen Pharmaceutical K.K.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-20
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-15
First Submit QC Date:
None
Study First Post Date:
2022-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-22
Last Update Post Date:
2025-05-23
Last Update Post Date Type:
ACTUAL